chr2-118974381-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_006770.4(MARCO):c.509C>T(p.Pro170Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000615 in 1,610,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_006770.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MARCO | NM_006770.4 | c.509C>T | p.Pro170Leu | missense_variant | 5/17 | ENST00000327097.5 | NP_006761.1 | |
MARCO | XM_011512082.3 | c.509C>T | p.Pro170Leu | missense_variant | 5/17 | XP_011510384.1 | ||
MARCO | XM_011512083.4 | c.146C>T | p.Pro49Leu | missense_variant | 2/14 | XP_011510385.1 | ||
MARCO | XM_017005171.3 | c.509C>T | p.Pro170Leu | missense_variant | 5/9 | XP_016860660.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MARCO | ENST00000327097.5 | c.509C>T | p.Pro170Leu | missense_variant | 5/17 | 1 | NM_006770.4 | ENSP00000318916 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000107 AC: 26AN: 242742Hom.: 0 AF XY: 0.0000837 AC XY: 11AN XY: 131408
GnomAD4 exome AF: 0.0000521 AC: 76AN: 1458672Hom.: 0 Cov.: 32 AF XY: 0.0000483 AC XY: 35AN XY: 725238
GnomAD4 genome AF: 0.000151 AC: 23AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74344
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 22, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at